In this online CME self-learning program:
The use of goal-directed therapy both improves outcomes and reduces costs in the perioperative setting. Dr. Cannesson discusses current practices and makes suggestions for practice improvements. He describes the challenges associated with peri-operative fluid management globally and shares the experience of UC – Irvine in the development of its “surgical home”.
The role of hemodynamic monitoring has direct implications, both in the near- and long-term, in predicting patient outcomes after surgery. The employment of hemodynamic monitoring and goal-directed therapy in a protocolized fashion improves post-operative complications within a given window of opportunity; this program examines the components of successful monitoring techniques and discusses how they may be applied to the overall surgical patient population. Employing findings both from a retrospective study he conducted and those of a wide-ranging meta-analysis, Dr. Manecke illustrates the association between peri-operative goal-directed therapy and post-operative complications and mortality.
Dr. Gan discusses the consequences of goal directed therapy and incorporating it into an enhanced recovery after surgery (ERAS) protocol. Minimally invasive methods to monitor cardiac output are also discussed, Dr. Gan suggests that the concept of individualized GDT is an integral component in the optimization of perioperative fluid management for high-risk surgical patients.
This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by Educational Grants from Edwards Lifesciences
Release Date: November 25, 2013 -- Expiration Date: November 25, 2015
Faculty: Gerald Manecke Jr., MD -- Maxime Cannesson, MD -- Tong (TJ) Gan, MB, FRCA, FFARCSI
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through content review ScientiaCME.
Faculty Disclosure: Dr. Cannesson, MD, PhD discloses that he is a consultant for Edwards Lifesciences, Masimo, and Covidien. Dr. Makecke, MD discloses that he is a consultant for Edwards Lifesciences. Dr. Gan, MD discloses that heis a consultant for Edwards Lifesciences and receiving research support from Baxter, Cheetah Medical, Covidien, Durect, Eisai, Edwards Life Science, Fresenius-Kabi and Hospira.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC, which has received a grant from the commercial supporter of this program: Edwards Lifesciences.
Commercial Support Disclosure: This program is supported by an educational grant from Edwards Lifesciences, a manufacturer of medical devices.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.